Archimedes Pharma Ltd Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Nottingham Vanuatu (1989)
Status: Acquired by Kyowa Hakko Kirin (2014)

Organization Overview

First Clinical Trial
2005
NCT00767221
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Archimedes Development Ltd | Archimedes Innovations, Pbc | Archimedes Pharma US, Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

fentanyl (Innovar) (4 trials)

hydromorphone (diladid) (1 trial)

Drugs in Phase 3 Trials (1)

morphine (1 trial)

Drugs in Phase 2 Trials (1)

budesonide (rhinocort) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cancer Pain (Phase 3)

Emergencies (Phase 4)

Glomerulonephritis, IGA (Phase 2)

Kidney Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 4